China Biopharmaceutical: The Phase III registered clinical trial of TQC2731 injection “TSLP monoclonal antibody” for maintenance treatment of chronic sinusitis with nasal polyps completed the enrollment of all participants.

Zhitongcaijing · 2d ago
China Biopharmaceutical: The Phase III registered clinical trial of TQC2731 injection “TSLP monoclonal antibody” for maintenance treatment of chronic sinusitis with nasal polyps completed the enrollment of all participants.